GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CEL-SCI Corp (FRA:LSRM) » Definitions » Accounts Payable

CEL-SCI (FRA:LSRM) Accounts Payable : €0.94 Mil (As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is CEL-SCI Accounts Payable?

CEL-SCI's Accounts Payable for the quarter that ended in Mar. 2024 was €0.94 Mil.

CEL-SCI's quarterly Accounts Payable declined from Sep. 2023 (€1.88 Mil) to Dec. 2023 (€1.05 Mil) and declined from Dec. 2023 (€1.05 Mil) to Mar. 2024 (€0.94 Mil).

CEL-SCI's annual Accounts Payable increased from Sep. 2021 (€1.43 Mil) to Sep. 2022 (€1.63 Mil) and increased from Sep. 2022 (€1.63 Mil) to Sep. 2023 (€1.88 Mil).

CEL-SCI Accounts Payable Historical Data

The historical data trend for CEL-SCI's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CEL-SCI Accounts Payable Chart

CEL-SCI Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.44 1.72 1.43 1.63 1.88

CEL-SCI Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.76 1.61 1.88 1.05 0.94

CEL-SCI Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

CEL-SCI Accounts Payable Related Terms

Thank you for viewing the detailed overview of CEL-SCI's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

CEL-SCI (FRA:LSRM) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CEL-SCI Corp (FRA:LSRM) » Definitions » Accounts Payable
Comparable Companies
TLSA MRNS IFRX TPST SPRO AFMD CGTX CMRX BTAI PASG OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB XBRU:ARGX BNTX
Traded in Other Exchanges
CVM:USA
Address
8229 Boone Boulevard, Suite 802, Vienna, VA, USA, 22182
Website
https://www.cel-sci.com
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The company is focused on activating the immune system to fight cancer and infectious diseases. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.

CEL-SCI (FRA:LSRM) Headlines

No Headlines